Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 213.60B P/E 37.80 EPS this Y 0.80% Ern Qtrly Grth 13.70%
Income 6.22B Forward P/E 22.40 EPS next Y 9.70% 50D Avg Chg 5.00%
Sales 42.35B PEG 4.09 EPS past 5Y 9.92% 200D Avg Chg 2.00%
Dividend N/A Price/Book 4.88 EPS next 5Y 6.90% 52W High Chg -9.00%
Recommedations 2.00 Quick Ratio 1.24 Shares Outstanding 382M 52W Low Chg 16.00%
Insider Own 0.18% ROA 4.83% Shares Float 381.14M Beta 0.78
Inst Own 90.95% ROE 13.53% Shares Shorted/Prior 3.99M/3.32M Price 553.76
Gross Margin 40.69% Profit Margin 14.69% Avg. Volume 1,704,174 Target Price 653.16
Oper. Margin 17.40% Earnings Date Oct 23 Volume 1,398,652 Change 1.45%
About Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Thermo Fisher Scientific Inc News
12/23/24 Jim Cramer Reports That Danaher Corporation (DHR)’s China Core Revenue Dropped By A ‘High-single-digit’ Percent In Q3
12/23/24 IQVIA (IQV) Surges 3.0%: Is This an Indication of Further Gains?
12/23/24 Pony AI, Thermo Fisher initiated: Wall Street's top analyst calls
12/21/24 Jim Cramer Reports That Thermo Fisher Scientific Inc. (TMO)’s China Sales Were Flat Year-Over-Year In The Nine Months Ending In September
12/18/24 Thermo Fisher (TMO) Stock Is Ready For Breakout, Here’s Why
12/17/24 Bioproduction Prospects to Drive TMO Shares Despite Macroeconomic Woes
12/16/24 The Zacks Analyst Blog Highlights Visa, Linde, Thermo Fisher Scientific, Tile Shop and Autoscope
12/13/24 Top Analyst Reports for Visa, Linde & Thermo Fisher Scientific
12/11/24 TMO Institutional & Insider Stock Sell-Offs Upset Market: How to Play
12/11/24 Should You Continue to Hold TMO Stock in Your Portfolio?
12/10/24 Strength Seen in AngioDynamics (ANGO): Can Its 23.3% Jump Turn into More Strength?
12/09/24 Nvidia Probed in China Over Possible Antimonopoly Violations
12/05/24 TMO Stock to Gain From the New Additions to CTS Portfolio of Products
12/04/24 Thermo Fisher Scientific Completes $1B Share Repurchase
12/03/24 Possible Bearish Signals With Thermo Fisher Scientific Insiders Disposing Stock
11/22/24 Thermo Fisher (TMO) Down 7.4% Since Last Earnings Report: Can It Rebound?
11/20/24 End Market Growth, New Acquisitions Drive Thermo Fisher's Shares
11/19/24 The Zacks Analyst Blog Highlights Thermo Fisher Scientific, NextEra Energy and Lowe's
11/18/24 Top Analyst Reports for Thermo Fisher, NextEra Energy & Lowe's
11/18/24 Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?
TMO Chatroom

User Image AlplaWarrior1 Posted - 50 minutes from now

$TMO $DGX 🚀🔥 ONEI wow! 🤫 In 10 business days, ONEI will be traded on the NYSE. This is a chance to get it at this cheap price. 🚀🫰 $0.45 yesterday, volume spiked to 369k, a 106% increase. My price target is $5 within the next two months. Who's in apes ? 🫡😉

User Image StockAutoPro Posted - 2 days ago

$TMO: A leader in scientific tools. Buy at $530 target $580. Thermo Fisher benefits from increased R&D spending in pharmaceuticals.

User Image Paco_the_Dirty_Gringo Posted - 3 days ago

$TMO is a leader in medical diagnostics, while $PTIX is advancing mental health treatments. Investors interested in healthcare innovation should consider adding both stocks to their portfolios.

User Image Stev_Davila Posted - 3 days ago

$BLK gonna support $MYNZ as $TMO & $DGX partnered with Mainz. Looks promising now.

User Image Imfromthefuture247 Posted - 3 days ago

$TMO yum

User Image Celikspur Posted - 4 days ago

This badass fam, green at close, all of them $DGX $TMO $MYNZ 🚀🔥

User Image HuxWilder Posted - 4 days ago

$MYNZ rumor got me now, upcoming FDA submission soon it’s real deal, a lot of HUGE news dropped recently like $DGX + $TMO partnership, both a multi-billion stocks, saw an alert about 1Q2025 FDA and this is 100% possible now that this will happens

User Image KamrynRich Posted - 5 days ago

$MYNZ don’t you get it? After FDA submission, it will get approval within 45 days and 100% positive w/ partners like $TMO $DGX

User Image Marisol_Guzman Posted - 5 days ago

$MYNZ can you imagine??? First $TMO second $DGX who’s next ??? TMO will help to develop, DGX will help for FDA and distribute = WIN WIN I’m loading up

User Image trading_momentum Posted - 5 days ago

I like $TMO, not sure why, lower channel band is at around 479, but it's been basing well, if it can maintain and bounce of the mid trendline and pass above 524 VWAP level, this should go back to 540 and oscillate between 500-550 for sometimes

User Image StockAutoPro Posted - 6 days ago

$TMO: Thermo Fisher Scientific at $528.84. Buy for $550 as life sciences R&D continues to expand globally.

User Image trade2livehappy Posted - 6 days ago

$TMO just need 1 jump to 550 to resume the uptrend. If tech money starts rotating tomorrow then possible

User Image cmacktrades Posted - 6 days ago

$MYNZ Just closed on an $8 million cash injection from an institutional investor at a 30%+ premium to current prices, regaining Nasdaq listing compliance as it has now been over 10 days with a closing bid above $1, partnering with $TMO to develop what could be a billion dollar non-invasive cancer screening product line-up, and prime target to be acquired by a larger health tech company. Worth the risk here in my opinion.

User Image CasperPuff Posted - 6 days ago

$TMO

User Image StockAutoPro Posted - 1 week ago

$TMO: At $526.89. Buy near $520 aiming to sell at $550. Thermo Fisher's role in scientific research equipment ensures demand stability.

User Image NGCS Posted - 1 week ago

@drtoughenstein I think you are right, but maybe reducing number of employees could also mean that they are going to reduce losses, and perhaps they do not need so many employees now because TMO already provides them with the commercial network, laboratory and administrative structure, for example. Also think that if the product already exists, perhaps the focus now is to make more money with that product and not start other lines of research. I think that at the beginning more money is spent, but with the product created there is no need for so many employees. We have to wait for a PR to know the terms of agreement with $TMO All the best

User Image VisionaryJack Posted - 1 week ago

$MYNZ Colorectal cancer is personal for me. I’m not just an advocate—I’m a fighter, facing this disease head-on while navigating misdiagnoses, treatment missteps, and a healthcare system that adds financial devastation to an already life-changing battle. But there’s hope. Mainz Biomed ($MYNZ) is not only advancing mRNA-based assays in collaboration with Thermo Fisher Scientific ($TMO), but they’re also pursuing another key partnership to accelerate their expansion into the U.S. and fast-track FDA approval. These efforts bring us closer to making early detection widely accessible, saving lives, and easing the crushing financial burden patients like me face. With CRC rates rising, especially among young people and Black communities, we must act now. $MYNZ’s innovations are a beacon of hope, and their commitment to expanding access is critical. I fight for myself—and for millions of others. Together, we can bring hope, break barriers, and save lives. #EarlyDetection #CancerAwareness

User Image ksoption Posted - 1 week ago

$SNOW $LLY $APP $TMO $TJX

User Image AveryCaldwell Posted - 1 week ago

$MYNZ or someone knows something, from -19% to +0.60% (20% recovery) anyway I’m in. With $TMO strong partnership it will rise for sure !!!

User Image NVDAMillionaire Posted - 1 week ago

$TMO Thermo Fisher Scientific Inc. (TMO): Empowering Scientific Breakthroughs and Driving Sustainable Growth https://beyondspx.com/article/thermo-fisher-scientific-inc-tmo-empowering-scientific-breakthroughs-and-driving-sustainable-growth

User Image DavyDaveCharts Posted - 1 week ago

$TMO 2 week chart: setting up for a potential 15% move in the coming weeks.

User Image trade2livehappy Posted - 1 week ago

$TMO didn't like the close. Still good in overall down market

User Image trade2livehappy Posted - 1 week ago

$TMO $DHR $LLY $MOH $UNH Isn’t this big news?

User Image CarolinesGrippy Posted - 1 week ago

@Thelionroarer asking myself the same. Still hate all these bearposters white knighting like children. $TMO partnership is the water wings holding up this anchor. Details being released could send it flying. Another possible catalyst is RFK not getting confirmed as HHS Secretary. Could very well trigger a reversal on the $XBI which would be bullish. I’m not even mad about the RS. The dilution is just ridiculous however and needs to stop.

User Image trade2livehappy Posted - 2 weeks ago

$TMO this will be 560 soon

User Image CarolinesGrippy Posted - 2 weeks ago

@peterb030 we are at 1.1 million volume in pre-split metrics. Not exactly nothing. Volume has remained higher than usual since $TMO news dropped.

User Image AllPenniesNoDividends Posted - 2 weeks ago

$EDSA $TMO Think about this… if another major virus outbreak happens and RFK Jr is running the show, it’s all about theraputics vs vaccines. EB05 had amazing numbers in level 7 COVID and TLR4 is a powerful player in ARDS. They believe it should be disease agnostic with plenty of data funded by the Canadian govt already

User Image AllPenniesNoDividends Posted - 2 weeks ago

$EDSA $TMO Also, there is soooo much more money in general ARDS vs specific types of cancer, etc.

User Image AllPenniesNoDividends Posted - 2 weeks ago

$EDSA according to BARDA trial page, trial should begin around 12/20/2024… EDSA, for the love of god, please PR when the first patient is dosed and how a division of $TMO (market cap over $200B) named PPD Development is running the trial to show big pharma has eyes all over it. Stir up some buzz for once. I mean the CEO of EDSA owns like 20% of the company. Don’t you want it to go up eventually vs staying silent and getting crushed. And reiterate the trial is being 100% paid for by the US government. https://clinicaltrials.gov/study/NCT06703073?term=Edesa&viewType=Table&rank=3

User Image Stantarizen Posted - 2 weeks ago

Alright, let’s light it up 🤑🚀 🚀 $META $600+ 💎 🔥 $TMO $650+ 🌕 💰 $CRM $500+ ⚡️ ⚡ $ MYNZ $500+ 🤑 Haters, keep watching—this train ain’t stopping! 😎

Analyst Ratings
Evercore ISI Group Outperform Oct 1, 24
Stephens & Co. Overweight Oct 1, 24
JP Morgan Overweight Sep 20, 24
Stifel Buy Sep 20, 24
RBC Capital Outperform Sep 20, 24
Morgan Stanley Overweight Sep 20, 24
B of A Securities Buy Sep 16, 24
Wells Fargo Overweight Aug 27, 24
TD Cowen Buy Jul 25, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Pettiti Gianluca Executive Vice Presi.. Executive Vice President Aug 30 Sell 557.77 3,000 1,673,310 17,556 08/31/23
Pettiti Gianluca Executive Vice Presi.. Executive Vice President Aug 30 Option 253.99 3,000 761,970 20,556 08/31/23
CASPER MARC N Chairman & CEO Chairman & CEO May 08 Sell 541.28 11,600 6,278,848 141,330 05/10/23
CASPER MARC N Chairman & CEO Chairman & CEO May 08 Option 157.68 11,600 1,829,088 142,930 05/10/23
Pettiti Gianluca Executive Vice Presi.. Executive Vice President Dec 13 Option 210.68 4,975 1,048,133 21,425 12/15/22
Pettiti Gianluca Executive Vice Presi.. Executive Vice President Dec 13 Sell 572.98 6,975 3,996,536 14,450 12/15/22
CASPER MARC N Chairman & CEO Chairman & CEO Nov 04 Option 129.77 18,100 2,348,837 186,105 11/08/22
CASPER MARC N Chairman & CEO Chairman & CEO Nov 04 Sell 491.78 18,100 8,901,218 178,005 11/08/22
CASPER MARC N Chairman & CEO Chairman & CEO Oct 31 Option 129.77 20,000 2,595,400 188,005 11/02/22
CASPER MARC N Chairman & CEO Chairman & CEO Oct 31 Sell 514.66 20,000 10,293,200 178,005 11/02/22
Williamson Stephen Sr. VP and CFO Sr. VP and CFO Aug 12 Option 157.68 27,300 4,304,664 56,244 08/16/22
Williamson Stephen Sr. VP and CFO Sr. VP and CFO Aug 12 Sell 602.98 27,300 16,461,354 43,944 08/16/22
Boxer Michael A SVP and General Coun.. SVP and General Counsel Aug 08 Option 192.98 7,283 1,405,473 19,681 08/10/22
Boxer Michael A SVP and General Coun.. SVP and General Counsel Aug 08 Sell 590.8 7,283 4,302,796 12,398 08/10/22
Lagarde Michel Executive Vice Presi.. Executive Vice President & COO May 26 Option 308.28 29,794 9,184,894 28,788 05/31/22
Lagarde Michel Executive Vice Presi.. Executive Vice President & COO May 26 Sell 550.77 29,794 16,409,641 15,758 05/31/22
Lagarde Michel Executive Vice Presi.. Executive Vice President & COO May 24 Option 237.32 22,198 5,268,029 20,806 05/25/22
Lagarde Michel Executive Vice Presi.. Executive Vice President & COO May 24 Sell 545.95 22,198 12,118,998 15,758 05/25/22
CASPER MARC N Chairman & CEO Chairman & CEO May 03 Sell 562.59 2,181 1,227,009 183,373 05/05/22
CASPER MARC N Chairman & CEO Chairman & CEO May 03 Option 129.77 20,000 2,595,400 193,373 05/05/22
Spar Debora L Director Director May 02 Sell 544.358 200 108,872 810 05/04/22
CASPER MARC N Chairman & CEO Chairman & CEO May 02 Option 129.77 10,000 1,297,700 193,373 05/04/22
CASPER MARC N Chairman & CEO Chairman & CEO May 02 Sell 544.98 10,000 5,449,800 183,373 05/04/22
MANZI JIM P Director Director Feb 14 Sell 563.95 1,500 845,925 16,252 02/15/22
CASPER MARC N Chairman & CEO Chairman & CEO Oct 28 Sell 484.63 20,000 9,692,600 211,594 10/28/20